Chimeric respiratory syncytial virus polypeptide antigens

Details for Australian Patent Application No. 2009270399 (hide)

Owner ID Biomedical Corporation of Quebec

Inventors Blais, Normand; Rheault, Patrick

Agent Davies Collison Cave

Pub. Number AU-A-2009270399

PCT Pub. Number WO2010/006447

Priority 61/081,888 18.07.08 US

Filing date 17 July 2009

Wipo publication date 21 January 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C12N 15/44 (2006.01) Mutation or genetic engineering

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/006447 Priority application(s): WO2010/006447

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270402-Privacy management for tracked devices

2009270398-Modified family 6 glycosidases with altered substrate specificity